Three-component synthesis and antibacterial activity of 5-Aryl-4-acyl-3-hydroxy-1-(4-methoxyphenyl)-3-pyrroline-2-ones

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

A series of new 5-aryl-4-acyl-3-hydroxy-1-(4-methoxyphenyl)-3-pyrrolin-2-ones was synthesized by the reacting of methyl esters of aroylpyruvic acids with a mixture of aromatic aldehyde and p-anisidine. Antibacterial activity of the obtained compounds was studied in vitro against Staphylococcus aureus and Escherichia coli strains.

Full Text

Restricted Access

About the authors

N. N. Kasimova

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: pufmail135@gmail.com
ORCID iD: 0009-0001-6348-7333
Russian Federation, Perm, 614990

O. O. Maiamsina

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation; Perm State Medical University named after Academician E. A. Wagner of the Ministry of Health of the Russian Federation

Email: pufmail135@gmail.com
Russian Federation, Perm, 614990; Perm, 614990

S. S. Dubrovina

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation

Email: pufmail135@gmail.com
Russian Federation, Perm, 614990

V. L. Gein

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation

Email: pufmail135@gmail.com
ORCID iD: 0000-0002-8512-0399
Russian Federation, Perm, 614990

References

  1. Afsah E.M., Abdelmageed S.M. // J. Heterocyclic Chem. 2020. Р. 1. doi: 10.1002/jhet.4098
  2. Manta S., Kollatos N., Mitsos C., Chatzieffraimidi G.-A., Papanastasiou I., Gallos J.K., Komiotis D. // Mini-Rev. Med. Chem. 2020. Vol. 20. N 10. P. 818. doi 10.2174/ 1389557520666200103123114
  3. Гейн О.Н., Рубцова Д.Д., Гейн В.Л. // Хим.-фарм. ж. 2022. Т. 56. № 12. С. 35. doi: 10.30906/0023-1134-2022-56-12-35-37
  4. Cusumano A.Q., Pierce J.G. // Bioorg. Med. Chem. Lett. 2018. Vol. 28. N 16. P. 2732. doi 10.1016/ j.bmcl.2018.02.047
  5. Joksimović N., Petronijević J., Janković N., Baskić D., Popović S., Todorović D., Matic S., Bogdanovic G.A., Vranes M., Tot A., Bugarčić Z. // Bioorg. Chem. 2019. Vol. 88. P. 102954. doi: 10.1016/j.bioorg.2019.102954
  6. Ahankar H., Ramazani А., Slepokura К., Lis Т., Joo S.W. // Green Chem. 2016. N 18. P. 3582. doi: 10.1039/c6gc00157b
  7. Машковский М.Д. Лекарственные средства. М.: Новая волна, 2024. 1216 с.
  8. Paguigan N.D., Yan Y., Karthikeyan M., Chase K., Carter J., Leavitt L.S., Lim A.L., Lin Z., Memon T., Christensen S., Bentzen B.H., Schmitt N., Reilly C.A., Teichert R.W., Raghuraman S., Olivera B.M., Schmidt E.W. // ACS Chem. Biol. 2021. Vol. 16. N 9. P. 1654. doi: 10.1021/acschembio.1c00328
  9. Duncan L.F., Wang G., Ilyichova O.V., Dhouib R., Totsika M., Scanlon M.J., Heras B., Abbott B.M. // Bioorg. Med. Chem. 2021. Vol. 45. P. 116315. doi 10.1016/ j.bmc.2021.116315
  10. Brown D.W., Denman C., OʼDonnell H. // J. Chem. Soc. (C). 1971. P. 3195. doi: 10.1039/J39710003195
  11. Ma K., Wang P., Fu W., Wan X., Zhou L., Chu Y., Ye D. // Bioorg. Med. Chem. Lett. 2011. Vol. 21. N 22. P. 6724. doi: 10.1016/j.bmcl.2011.09.054
  12. Gein V.L., Chalkov D.V., Romanova A.V., Bobrovskaya O.V., Chashchina S.V., Dmitriev M.V. // Russ. J. Org. Chem. 2025. Vol. 61. N 1. P. 16. doi: 10.1134/S1070428025010026
  13. Гейн В.Л., Гейн Л.Ф., Безматерных Э.Н., Шуров С.Н. // ЖОХ. 2000. Т. 70. Вып. 10. С. 1692.
  14. Руководство по проведению доклинических исследований лекарственных средств / Под ред. А.Н. Миронова. М.: Гриф и К, 2012. Ч. 1. 944 с.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Scheme 1. R1 = ОEt, R2 = 4-Br (1); R1 = ОEt, R2 = 4-NO2 (2); R1 = Cl, R2 = H (3); R1 = NO2, R2 = H (4); R1 = ОEt, R2 = 3-NO2 (5); R1 = ОEt, R2 = 2-F (6); R1 = ОEt, R2 = H (7); R1 = NO2, R2 = 2,4-(MeO)2 (8); R1 = ОEt, R2 = 2-NO2 (9); R1 = ОEt, R2 = 4-MeO (10).

Download (489KB)
3. Scheme 2.

Download (576KB)
4. Scheme 3.

Download (600KB)

Copyright (c) 2025 Russian Academy of Sciences